Clinicopathological and molecular significance of HER2-low expression in Asian women with triple-negative breast cancer
Background: Heterogeneity of human epidermal growth factor receptor 2 (HER2) expression exists in triple-negative breast cancer (TNBC). The evolution of the HER2 testing algorithm has led to the new classification of the HER2-low category, with unclear clinicopathological and molecular features in A...
Saved in:
Main Authors: | Cuiyan Yang, Haoyu Wang, Yiwei Tong, Zheng Wang, Xi Sun, Anqi Li, Yujie Lu, Mengyuan Han, Siji Zhu, Lei Dong, Kunwei Shen, Xiaosong Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2025-07-01
|
Series: | Therapeutic Advances in Medical Oncology |
Online Access: | https://doi.org/10.1177/17588359251353083 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prevalence and Clinicopathologic Features of HER2 Overexpression in Endocervical Adenocarcinoma
by: Niusha Momeni, et al.
Published: (2025-07-01) -
HER3, but Not HER4, Plays an Essential Role in the Clinicopathology and Prognosis of Gastric Cancer: A Meta-Analysis.
by: Guo-Dong Cao, et al.
Published: (2016-01-01) -
TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER
by: A. D. Zikiryakhodzhaev, et al.
Published: (2017-06-01) -
Characterization of Triple Negative Breast Cancer
by: Bernardo Enrique Heredia Martínez, et al.
Published: (2020-09-01) -
Clinicopathological significance of c-MYC in esophageal squamous cell carcinoma
by: Yu Lian, et al.
Published: (2017-06-01)